Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats (Q44167763)

30 November 2017

title

Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats (English)

1 reference

30 November 2017

1 reference

Lourdes Lorigados Pedre

1

1 reference

30 November 2017

Nancy Pavón Fuentes

2

1 reference

30 November 2017

Lázaro Alvarez González

3

1 reference

30 November 2017

Amanda McRae

4

1 reference

30 November 2017

Teresa Serrano Sánchez

5

1 reference

30 November 2017

Lissette Blanco Lescano

6

1 reference

30 November 2017

Raúl Macías González

7

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

952

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

122-127

1 reference

Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Haloperidol Administration in Humans Lowers Plasma Nerve Growth Factor Level: Evidence that Sedation Induces Opposite Effects to Arousal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Altered plasma levels of nerve growth factor and transforming growth factor-beta2 in type-1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Pathoanatomy of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

The role of neuronal growth factors in neurodegenerative disorders of the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

NGF in CNS: experimental data and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Regulation of nerve growth factor synthesis/secretion by catecholamine in cultured mouse astroglial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Cardiac sympathetic denervation in Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

The time course of nerve growth factor content in different neuropsychiatric diseases--a unifying hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Parkinsonism: onset, progression, and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Two-site enzyme immunoassay for nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Mast cells synthesize, store, and release nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Two-site enzyme immunoassay for beta NGF applied to human patient sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Characterization and isolation of proteolytically modified nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1β and nerve growth factor in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Medial nigral dopamine neurons have rich neurotrophin support in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

In vivo activated brain astrocytes may produce and secrete nerve growth factor-like molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Etiology and pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Nerve growth factor induces growth and differentiation of human B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Neurotrophic factors in Alzheimer's and Parkinson's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

Recombinant human beta-nerve growth factor (NGF): biological activity and properties in an enzyme immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)03222-5

10.1016/S0006-8993(02)03222-5

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference